Medications

FDA approves Biogen's MS drug Plegridy

Biogen Idec says that federal regulators have approved the specialty drugmaker's new treatment for people with relapsing forms of multiple sclerosis.

Neuroscience

Dice loaded for patients with late-stage MS, study shows

People living with multiple sclerosis have the dice loaded against them when it comes to their decision-making ability as their neurological disease progresses, according to a new study from the University of Alberta's Faculty ...

Neuroscience

Quantity, not just quality, in new Stanford brain scan method

(Medical Xpress)—Imagine that your mechanic tells you that your brake pads seem thin, but doesn't know how long they will last. Or that your doctor says your child has a temperature, but isn't sure how high. Quantitative ...

Neuroscience

Predicting who will develop multiple sclerosis

A team of investigators at Brigham and Women's Hospital (BWH) and the National Institute of Neurological Disorders and Stroke (NINDS) has launched a study of individuals at risk for multiple sclerosis (MS). By focusing on ...

page 26 from 40